Computer-aided drug discovery: historical foundations, practical AI tools, and emerging ethical considerations
Frontiers in Pharmacology · 24.06.2026 · 17
DOI: 10.3389/fphar.2026.1866562 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 24.06.2026. Verfasst von Rebekah Clarke und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, Faculty of Medicine, Health and Life Science, Swansea University, Swansea, United Kingdom. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Computer-aided drug discovery (CADD) has become an integral component of modern drug development, supporting hit identification, lead optimisation, and candidate refinement across both academia and industry. Over 4 decades of methodological progress have contributed to the discovery or optimisation of several approved therapeutics, establishing CADD as a crucial element of drug research. In parallel, recent advances in artificial intelligence (AI) and machine learning (ML) have introduced a new generation of practical tools that offer improved predictive performance, accessible software implementations, and increasing integration into everyday drug discovery and pharmacology workflows. This review provides a concise historical overview of CADD, with an updated account of approved drugs and clinical-stage candidates whose discovery or optimisation has involved computational methods and highlights a curated set of contemporary AI and ML tools that are readily usable by non-specialists. In addition, we compile and analyse two comprehensive, practice-oriented resources: a collection of cloud-based virtual-screening platforms, and an extensive suite of freely accessible ADMET prediction tools, offering medicinal chemists a consolidated guide to open-source computational workflows. Finally, we discuss emerging ethical considerations, including data bias, transparency, computational costs, and the environmental impact of large-scale models, outlining responsible paths for the continued adoption of AI in drug discovery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical School, Faculty of Medicine, Health and Life Science, Swansea University, Swansea, United Kingdom.
- School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, United Kingdom.
Zitieren
APA
Clarke, R., Palazzo, G., Ruzicka, J., Ferla, S., & Bassetto, M. (2026). Computer-aided drug discovery: historical foundations, practical AI tools, and emerging ethical considerations. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1866562
Vancouver
Clarke R, Palazzo G, Ruzicka J, Ferla S, Bassetto M. Computer-aided drug discovery: historical foundations, practical AI tools, and emerging ethical considerations. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1866562
BibTeX
@article{Clarke2026,
author = {Clarke, Rebekah and Palazzo, Giuseppe and Ruzicka, Jiri and Ferla, Salvatore and Bassetto, Marcella},
title = {Computer-aided drug discovery: historical foundations, practical AI tools, and emerging ethical considerations},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1866562}
}
EUVIMED